tiprankstipranks

Control Bionics Expands with NeuroStrip Commercial Agreements

Control Bionics Expands with NeuroStrip Commercial Agreements

Control Bionics Ltd. (AU:CBL) has released an update.

Confident Investing Starts Here:

Control Bionics Limited, a leader in EMG medical device technology, is set to expand its market presence with its NeuroStrip® technology securing commercial agreements in U.S. sports performance and Japanese rehabilitation sectors. The company is hosting an online Investor Briefing to discuss these developments and provide a company update. This move marks a significant step for Control Bionics in leveraging its patented technology across new markets.

For further insights into AU:CBL stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1